A Phase 1 interventional study of Cannabis and Placebo in Spinal Cord Injury, sponsored by Khon Kaen University. Enrolling by invitation at 1 site in Thailand. Open to participants aged 25 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-03-08.
Sponsored by Khon Kaen University · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Spinal Cord Injuries with a site in Thailand — 2 open to participants now, 2 under way, none of them phase 3. Spinal Cord Injuries · Thailand.
Among the 10 studies in Spinal Cord Injuries with a site in Thailand, this one is one of 3 that started in 2024, is the only one in phase 1, and was the 8th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →2 of the 10 studies in Spinal Cord Injuries with a site in Thailand are open now. Recruiting first, the newest first:
Khon Kaen University · Sites in Thailand
Ages 18+
A study can be open while its sites in Thailand have not opened yet or have stopped. Only those recruiting at a site in Thailand →
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 25 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 3 started in 2024.
This study's planned enrollment of 20 is below the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 32 across the 8 interventional studies, 102 across the 2 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 10 has an industry lead sponsor. The 3 most frequent:
Khon Kaen University is the lead sponsor of 161 studies on the registry; 24 are open to participants now.
Khon Kaen University has 9 studies filed under Spinal Cord Injuries — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Spinal Cord Injuries with a site in Thailand, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to compare effects of marijuana or cannabis on neuropathic pain and spasticity in spinal cord injury patients. The main question is: Does the cannabis product from KhonKaen University reduce neuropathic pain and spasticity in spinal cord injury patients? The research design is a crossover study. The participants will be randomly into 2 groups: group 1 and group 2. The participants received either cannabis or placebo for 2 weeks. After completing treatment, participants were swapped to the other group for 2 weeks, a wash-out period is 2 weeks. The outcome measurements are pain and spasticity.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The participants will receive cannabis product for 2 weeks. The participants will receive the cannabis product (THC 30mg / 1 ml) manufactured by Faculty of pharmaceutical science KhonKaen University. The participants will gradually increase using the product starting from 1 drop (1.5 mg THC) per day sublingually and can increase using not more than 1 drop per day, until pain or spasticity can be controlled.
Drug: Cannabis
The participants will receive placebo product manufactured by Faculty of Pharmaceutical Science KhonKaen University for 2 weeks. The participants will gradually increase using the product starting from 1 drop per day sublingually and can increase using not more than 1 drop per day,
Drug: Placebo
Cannabis product is from the extraction of the powdered, dried and mature pistillate inflorescences of Cannabis sativa L. containing THC 30mg/ml.
Also known as: Marijuana
Placebo is similar to Cannabis product but do not contain THC.
Also known as: Control/ No cannabis
Pain score
Visual analog scale
Time frame: 2 weeks
Spasticity
Modified Asworth Score
Time frame: 2 weeks
Activities of daily living
to assess functional outcome
Time frame: 2 weeks
Quality of life score
WHO Bref Quality of life questionnaire
Time frame: 2 weeks
H-reflex
Electrodiagnosis
Time frame: 2 weeks
Plan to share: Yes — Individual participant data that underlie the results reported in this article after deidentification.
Supporting information: Study protocol, Clinical study report
Time frame: beginning 3 months and ending 5 years following article published
Access criteria: Researchers who provide a methodologically sound proposal.
No publications or documents are linked to this record.
Started Jan 2024 (actual). Primary completion is estimated for Jun 2024, 5 months after the start.
Of 40 non-industry phase 1 interventional studies under Spinal Cord Injuries, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 25 and three quarters within 55. This study's planned 5 months is below that.
Counting every sponsor, half of 51 studies reached it within 36 months; a quarter within 24 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Cannabis sativa subsp. indica TOP